Successful Neuromuscular Blockade Reversal Using Sugammadex and Neostigmine Failed to Prevent Myasthenic Crisis After Emergency Surgery: A Case Report

被引:2
作者
Haddad, Daniel [1 ]
Hanna, Adeeb J. [1 ]
Russo, Lori [2 ]
机构
[1] Rowan Univ, Med, Sch Osteopath Med, Stratford, NJ 08084 USA
[2] Hackensack Meridian Ocean Med Ctr, Anesthesiol, North Amer Partners Anesthesia NAPA, Brick, NJ USA
关键词
post-operative management; myasthenic exacerbation; emergency surgery; sugammadex; neostigmine; neuromuscular blockade (nmb); myasthenia gravis (mg); GRAVIS;
D O I
10.7759/cureus.27366
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Recent literature suggests that the use of sugammadex for the reversal of neuromuscular blocking agents (NMBAs) reduces the risk of postoperative myasthenic crisis (MC) in patients with myasthenia gravis (MG), particularly after thymectomy, but studies are lacking on emergency surgeries. We achieved successful intraoperative reversal of neuromuscular blockade (NMB) using a combination of sugammadex and neostigmine (with glycopyrrolate). However, MC was not avoided and reintubation was required on postoperative day 1. A 65-year-old male with a longstanding history of MG presented to the emergency department with complaints of abdominal pain, diarrhea, vomiting, chills, and fatigue for three days. A computed tomography (CT) scan of the abdomen showed acute appendicitis, for which he underwent a laparoscopic appendectomy on hospital day 1. The patient received successful general anesthesia with a rapid sequence induction using a smaller than average dose of rocuronium, given his history of MG. At the conclusion of the case, sugammadex followed by neostigmine/glycopyrrolate and a subsequent dose of sugammadex were given, with reversal of NMB. The patient was successfully extubated but required reintubation on postoperative day 1 for hypercapnic respiratory failure. Our case report on this patient with MG yields two topics that have not been extensively examined. First, dual therapy with sugammadex and neostigmine/glycopyrrolate may provide significant clinical benefit over individual therapy for NMBA reversal, given that their mechanisms of action are different and particularly when sugammadex is given prior to neostigmine/glycopyrrolate. Second, anesthesia literature is lacking on MG patients undergoing emergency surgeries. While sugammadex has been promising in medically optimized non-emergent surgeries, we discuss here a case where sugammadex failed to prevent MC in the emergency surgery setting and a look into what may provide patients with the best chance for avoiding postoperative MC.
引用
收藏
页数:5
相关论文
共 16 条
  • [1] Half dose sugammadex combined with neostigmine is non-inferior to full dose sugammadex for reversal of rocuronium-induced deep neuromuscular blockade: a cost-saving strategy
    Aouad, Marie T.
    Alfahel, Waseem S.
    Kaddoum, Roland N.
    Siddik-Sayyid, Sahar M.
    [J]. BMC ANESTHESIOLOGY, 2017, 17
  • [2] Sugammadex in the management of myasthenic patients undergoing surgery: beyond expectations
    Carron, Michele
    De Cassai, Alessandro
    Linassi, Federico
    [J]. ANNALS OF TRANSLATIONAL MEDICINE, 2019, 7
  • [3] Efficacy and safety of sugammadex compared to neostigmine for reversal of neuromuscular blockade: a meta-analysis of randomized controlled trials
    Carron, Michele
    Zarantonello, Francesco
    Tellaroli, Paola
    Ori, Carlo
    [J]. JOURNAL OF CLINICAL ANESTHESIA, 2016, 35 : 1 - 12
  • [4] High-dose rocuronium for rapid-sequence induction and reversal with sugammadex in two myasthenic patients
    Casarotti, P.
    Mendola, C.
    Cammarota, G.
    Della Corte, F.
    [J]. ACTA ANAESTHESIOLOGICA SCANDINAVICA, 2014, 58 (09) : 1154 - 1158
  • [5] The combination of sugammadex and neostigmine can reduce the dosage of sugammadex during recovery from the moderate neuromuscular blockade
    Cheong, Soon Ho
    Ki, Seunghee
    Lee, Jiyong
    Lee, Jeong Han
    Kim, Myoung-Hun
    Hur, Dongki
    Cho, Kwangrae
    Lim, Se Hun
    Lee, Kun Moo
    Kim, Young-Jae
    Lee, Wonjin
    [J]. KOREAN JOURNAL OF ANESTHESIOLOGY, 2015, 68 (06) : 547 - 555
  • [6] Collins Shawn, 2020, AANA J, V88, P485
  • [7] Reversal of neuromuscular blockade with sugammadex in patients with myasthenia gravis A case series of 21 patients and review of the literature
    de Boer, Hans D.
    Shields, Martin O.
    Booij, Leo H. D. J.
    [J]. EUROPEAN JOURNAL OF ANAESTHESIOLOGY, 2014, 31 (12) : 715 - 721
  • [8] Myasthenia gravis and sugammadex: A case report and review of the literature
    Dontukurthy, Sujana
    Wisler, Carrie
    Raman, Vidya
    Tobias, Joseph D.
    [J]. SAUDI JOURNAL OF ANAESTHESIA, 2020, 14 (02) : 244 - 248
  • [9] Efficacy and safety of sugammadex versus neostigmine in reversing neuromuscular blockade in adults
    Hristovska, Ana-Marija
    Duch, Patricia
    Allingstrup, Mikkel
    Afshari, Arash
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2017, (08):
  • [10] Sugammadex versus Neostigmine for Reversal of Neuromuscular Blockade and Postoperative Pulmonary Complications (STRONGER): A Multicenter Matched Cohort Analysis
    Kheterpal, Sachin
    Vaughn, Michelle T.
    Dubovoy, Timur Z.
    Shah, Nirav J.
    Bash, Lori D.
    Colquhoun, Douglas A.
    Shanks, Amy M.
    Mathis, Michael R.
    Soto, Roy G.
    Bardia, Amit
    Bartels, Karsten
    McCormick, Patrick J.
    Schonberger, Robert B.
    Saager, Leif
    [J]. ANESTHESIOLOGY, 2020, 132 (06) : 1371 - 1381